Lung Cancer | Tumor

Evaluating Existing and Future Surgical Options for Early-Stage Lung Cancer

November 23rd 2022

As part of its “Speaking Out” video series, Dr. Peter Baik, on behalf of Cancer Treatment Centers of America, discussed how far the space has come with surgical advances, and where it is headed, in treating early-stage lung cancer.

‘Time is of the Essence’ in Decision-Making for Early-Stage Lung Cancer

November 23rd 2022

As part of its “Speaking Out” video series, Dr. Peter Baik, on behalf of Cancer Treatment Centers of America, discussed the importance of timing and decision-making of treatment in early-stage lung cancer.

Expert Addresses Disparities in Lung Cancer Screening, What More Can Be Done

November 23rd 2022

As part of its “Speaking Out” video series, Dr. Peter Baik, on behalf of Cancer Treatment Centers of America, discussed disparities seen in lung cancer screening and what more can be done.

Libtayo’s Approval Part of the ‘Renaissance’ of Lung Cancer Advancements

November 18th 2022

The recent FDA approval of Libtayo for advanced non-small cell lung cancer added yet another option for the treatment of patients with the disease.

‘Star Trek’ Actors Team Up for Cancer Research, Michelle Obama Meets a Sarcoma Survivor and More

November 18th 2022

From “Star Trek” actors supporting the Pancreatic Cancer Action Network to Michelle Obama meeting with a sarcoma survivor and an update on Jane Fonda’s cancer, here’s what’s happening in the cancer space this week.

A Glimmer of Hope for Those With Lung Cancer

November 16th 2022

Screening After a Lung Cancer Diagnosis

November 15th 2022

Does lung cancer screening continue after a person is finished with treatment and moves in to the survivorship stage?

Biomarker Testing Provides 'Real Potential' to Manage Lung Cancer

November 14th 2022

Identifying genetic mutations in lung cancer has allowed researchers to develop treatments that target specific biomarkers over the past 20 years, but more research is needed to further the space.

'Considerable Overlap’ in Appearance of Chest Abnormalities May Delay Lung Cancer Diagnoses

November 14th 2022

Patients should describe their symptoms in detail and seek early care for suspected lung cancer, especially since the disease may resemble pneumonia and bronchitis on imaging tests.

Improving Breathing After Lobectomy

November 11th 2022

Light exercises, which can be done at home, may be beneficial for patients with lung cancer.

FDA Approves Imjudo With Imfinzi and Chemo for Metastatic NSCLC Without Certain Genetic Mutations

November 10th 2022

Imjudo, Imfinzi and chemotherapy improved overall and progression-free survival in certain patients with non-small cell lung cancer.

Targeting the 'Typos' for Lung Cancer Harboring Rare Genetic Mutations

November 9th 2022

New treatments may stall lung cancer progression in patients with EGFR exon 20 insertion mutations.

FDA Approves Libtayo Plus Chemotherapy for Advanced Lung Cancer Subset

November 9th 2022

The Food and Drug Administration approved Libtayo plus chemotherapy for certain patients with non-small cell lung cancer.

Detecting Lung Cancer on the Move

November 8th 2022

Tumors can spread from one lung to the other and beyond. How are possible cancer metastases diagnosed in early stages?

Providing Hope to Patients With Cancer Is the Best Part of the Job, Says an Oncologist

November 7th 2022

With advancements making a “huge difference” in lung cancer outcomes, one surgical oncologist said that offering his patients hope is the best part of his job.

Clinical Trial Kicks Off Evaluating a New Drug for a Group of Solid Cancers

November 4th 2022

A novel drug, MRT-2359, will be studied in a phase 1/2 trial for patients with MYC-driven cancers.

End-of-Life Discussions Can ‘Lay Out a Roadmap’ of Patient Wishes and Avoid Unnecessary Cancer Care

November 2nd 2022

Talking about the end of life can be difficult, but these conversations are crucial for patients with incurable cancer to have with their clinicians, experts say.

A Lung Cancer Diagnosis Inspired a Research Nurse to Fight Stigma Around the Disease

October 31st 2022

After receiving a life-changing lung cancer diagnosis, Alesha Arnold was inspired to give back to her community and improve the lives of patients with the disease.

Reading the Fine Print: How a Footnote on a CT Scan Led to an Unexpected Lung Cancer Diagnosis

October 27th 2022

A man shares how reading the footnote of a CT scan looking for heart disease alerted him to a mass in his right lung, leading to an unexpected diagnosis of lung cancer.

Educated Patient® Lung Cancer Summit Supportive Care Panel: October 1, 2022

October 22nd 2022

Watch Dr. Hossein Borghaei, Dr. Jessica R. Bauman and Dr. Devika Das answer questions about supportive care during the CURE Educated Patient Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Telemedicine in Oncology Supportive Care Presentation: October 1, 2022

October 21st 2022

Watch Dr. Devika Das, from University of Alabama at Birmingham Medicine, discuss the benefits of telemedicine in cancer care during the CURE® Educated Patient® Lung Cancer Summit.

Patient With Lung Cancer ‘Stays One Step Ahead’ of His Rare Mutation

October 20th 2022

A man with lung cancer shares how learning about his EGFR exon 20 insertion mutation soon after being diagnosed has allowed him to be aggressive when pursuing a cancer treatment tailored to his rare mutation.

Educated Patient® Lung Cancer Summit Early Introduction to Palliative Care Presentation: October 1, 2022

October 20th 2022

Watch Dr. Jessica R. Bauman, from Fox Chase Cancer Center, discuss palliative care during the CURE Educated Patient Lung Cancer Summit.

Lumakras-Novel Drug Combination to Be Studied in KRAS-Mutant Lung Cancer, Solid Tumors

October 19th 2022

A clinical trial recently kicked off to study the effects of combining the novel drug BBP-398 plus Lumakras in patients with lung cancer that harbors a KRAS G12 mutation.

Educated Patient® Lung Cancer Summit Management of Advanced/Metastatic Disease Panel: October 1, 2022

October 19th 2022

Watch Dr. Hossein Borghaei, Dr. David Gerber, Dr. Aaron S. Mansfield and Dana M. Haagen answer questions on the management of advanced/metastatic disease during the CURE Educated Patient Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Joining Clinical Trials Presentation: October 1, 2022

October 18th 2022

Watch Dana Haagen, from Fox Chase Cancer Center, discuss clinical trials and how patients can join them, during the CURE® Educated Patient® Lung Cancer Summit.

Newer Lung Cancer Treatments Offer Improved Outcomes That are a ‘Whole Other Ballgame’ for Patients, Says Expert

October 17th 2022

An expert offers insight into the major treatment improvements over the past 20 years for early-stage and late-stage lung cancer.

Educated Patient® Lung Cancer Summit Managing Mesothelioma Presentation: October 1, 2022

October 17th 2022

Watch Dr. Aaron S. Mansfield, from Mayo Clinic, discuss the management of mesothelioma during the CURE Educated Patient Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Antibody Drug Conjugates Presentation: October 1, 2022

October 16th 2022

Watch Dr. David Gerber, from UT Southwestern Medical Center, discuss antibody drug conjugates during the CURE Educated Patient Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Management of Early Disease Panel: October 1, 2022

October 15th 2022

Watch Dr. Hossein Borghaei, Dr. Jared Weiss and Dr. Anne Chiang answer questions about early disease management during the CURE Educated Patient Lung Cancer Summit.